NO20053730L - Pyridinderivater anvendelig for hemming av natrium/kalsium-utbyttingssystem - Google Patents

Pyridinderivater anvendelig for hemming av natrium/kalsium-utbyttingssystem

Info

Publication number
NO20053730L
NO20053730L NO20053730A NO20053730A NO20053730L NO 20053730 L NO20053730 L NO 20053730L NO 20053730 A NO20053730 A NO 20053730A NO 20053730 A NO20053730 A NO 20053730A NO 20053730 L NO20053730 L NO 20053730L
Authority
NO
Norway
Prior art keywords
formula
halogen
nhc
group
ch2nr15r18
Prior art date
Application number
NO20053730A
Other languages
English (en)
Norwegian (no)
Other versions
NO20053730D0 (no
Inventor
Jouko Levijoki
Tuula Koskelainen
Leena Otsomaa
Sirpa Rasku
Arto Karjalainen
Piero Pollesello
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8565286&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20053730(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corp filed Critical Orion Corp
Publication of NO20053730D0 publication Critical patent/NO20053730D0/no
Publication of NO20053730L publication Critical patent/NO20053730L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D411/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20053730A 2003-01-09 2005-08-03 Pyridinderivater anvendelig for hemming av natrium/kalsium-utbyttingssystem NO20053730L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20030030A FI20030030A0 (fi) 2003-01-09 2003-01-09 Uusia yhdisteitä
PCT/FI2004/000011 WO2004063191A1 (en) 2003-01-09 2004-01-09 Pyridine derivatives useful for inhibiting sodium/calcium exchange system

Publications (2)

Publication Number Publication Date
NO20053730D0 NO20053730D0 (no) 2005-08-03
NO20053730L true NO20053730L (no) 2005-10-07

Family

ID=8565286

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053730A NO20053730L (no) 2003-01-09 2005-08-03 Pyridinderivater anvendelig for hemming av natrium/kalsium-utbyttingssystem

Country Status (22)

Country Link
US (1) US7482340B2 (ru)
EP (1) EP1583759A1 (ru)
JP (1) JP2006516271A (ru)
KR (1) KR20050095601A (ru)
CN (1) CN100457752C (ru)
AR (1) AR042733A1 (ru)
AU (1) AU2004203943B2 (ru)
BR (1) BRPI0406669A (ru)
CA (1) CA2512184A1 (ru)
EA (1) EA008539B1 (ru)
FI (1) FI20030030A0 (ru)
HR (1) HRP20050703A2 (ru)
IL (1) IL169435A0 (ru)
IS (1) IS7969A (ru)
MX (1) MXPA05007435A (ru)
NO (1) NO20053730L (ru)
NZ (1) NZ541087A (ru)
PL (1) PL378326A1 (ru)
RS (1) RS20050528A (ru)
UA (1) UA81941C2 (ru)
WO (1) WO2004063191A1 (ru)
ZA (1) ZA200505461B (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20011507A0 (fi) * 2001-07-10 2001-07-10 Orion Corp Uusia yhdisteitä
KR101233223B1 (ko) * 2004-12-21 2013-02-14 제이엔씨 석유 화학 주식회사 크로만환을 가지는 액정 화합물, 액정 조성물 및 이 액정조성물을 함유하는 액정 표시소자
UA109896C2 (xx) 2007-02-22 2015-10-26 Похідні імінопіридину та їх застосування як мікробіоцидів
JP5913357B2 (ja) * 2010-12-06 2016-04-27 アウトイフオンイ トヘラペウトイクス リミテッド Kv3阻害剤として有用なヒダントイン誘導体
EP2524908A1 (en) 2011-05-20 2012-11-21 LEK Pharmaceuticals d.d. Process for the preparation of alfa-substituted ketones and their application in synthesis of pharmaceutically active compounds
PT2567958E (pt) * 2011-09-12 2015-01-14 Sanofi Sa 2-(croman-6-iloxi)-tiazoles substituídos e sua utilização como produtos farmacêuticos
JP5941637B2 (ja) * 2011-09-12 2016-06-29 サノフイ 置換2−(クロマン−6−イルオキシ)−チアゾール及び医薬としてのその使用
US8912224B2 (en) 2011-09-12 2014-12-16 Sanofi Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
KR101817925B1 (ko) 2011-09-12 2018-01-12 사노피 치환된 2-(크로만-6-일옥시)-티아졸 및 약제로서의 이의 용도
WO2013144191A1 (de) * 2012-03-29 2013-10-03 Bayer Intellectual Property Gmbh Substituierte 2 -amino - 3 - cyanopyridine als inhibitoren des natrium calcium austausches und ihre verwendung bei kardiovaskulären erkrankungen
TWI633095B (zh) 2013-03-08 2018-08-21 賽諾菲公司 經取代-6-基氧基-環烷類及其作為醫藥品之用途
GB201416186D0 (en) 2014-09-12 2014-10-29 Redx Pharma Ltd Compounds
KR102594441B1 (ko) 2015-03-06 2023-10-25 파마케아, 인크. 플루오르화된 리실 옥시다아제-유사 2 억제제 및 이의 용도
EP3265445B1 (en) 2015-03-06 2021-05-05 Pharmakea, Inc. Lysyl oxidase-like 2 inhibitors and uses thereof
KR102573450B1 (ko) * 2015-08-19 2023-08-31 닛산 가가쿠 가부시키가이샤 액정 배향제 등에 사용되는 신규의 이미드계 중합체
CN109983006B (zh) 2016-09-07 2022-02-25 法玛克亚公司 赖氨酰氧化酶样2抑制剂的结晶形式及其制备方法
CN117180280A (zh) 2016-09-07 2023-12-08 法玛克亚公司 赖氨酰氧化酶样2抑制剂的用途
WO2019175464A1 (en) 2018-03-14 2019-09-19 Orion Corporation Compounds useful as inhibitors of sodium-calcium exchanger (ncx)
CA3187514A1 (en) 2020-07-28 2022-02-03 Andrew BELFIELD Fused bicyclic raf inhibitors and methods for use thereof
CN115850258B (zh) * 2022-12-27 2024-09-24 东北林业大学 一种马赛替尼的合成方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2820817A (en) 1954-02-04 1958-01-21 Mcneilab Inc Oxygenated indan compounds and method of making the same
US3862232A (en) 1963-07-03 1975-01-21 Upjohn Co 1-(p-hydroxyphenyl)-2-phenyl-6-(2-diethylaminoethoxy)-3,4-dihydronaphthalene and the salts thereof
BE650081A (ru) 1963-07-03
GB1154119A (en) 1968-05-20 1969-06-04 Merck Ag E 3-Alkyl-Flavanones
JPH04113839A (ja) * 1990-09-05 1992-04-15 Mitsubishi Petrochem Co Ltd ポリカーボネート樹脂積層物
FR2733685B1 (fr) 1995-05-05 1997-05-30 Adir Utilisation des derives du benzopyrane pour l'obtention de compositions pharmaceutiques destinees au traitement des pathologies liees a l'echangeur c1-/hc03-, na+ independant
JPH0967336A (ja) 1995-09-04 1997-03-11 Kanebo Ltd 新規なイソチオウレア誘導体
US6156801A (en) 1997-03-27 2000-12-05 Taisho Pharmaceutical Co., Ltd. 2-phenoxyaniline derivatives
JPH1149752A (ja) * 1997-08-05 1999-02-23 Taisho Pharmaceut Co Ltd フェノキシピリジン誘導体
DE19742508A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
KR20010031212A (ko) 1997-10-20 2001-04-16 우에하라 아끼라 2-페녹시아닐린 유도체
JPH11302235A (ja) 1998-04-15 1999-11-02 Taisho Pharmaceut Co Ltd フェノキシアルキルアミン誘導体
AU4360200A (en) 1999-04-23 2000-11-10 Bristol-Myers Squibb Company Bicyclic acyl guanidine sodium/proton exchange inhibitors and method
SK3292002A3 (en) 1999-09-17 2003-04-01 Nissan Chemical Ind Ltd Benzopyran derivative
FI20011507A0 (fi) * 2001-07-10 2001-07-10 Orion Corp Uusia yhdisteitä

Also Published As

Publication number Publication date
ZA200505461B (en) 2006-03-29
US20060241147A1 (en) 2006-10-26
BRPI0406669A (pt) 2005-12-20
AU2004203943A1 (en) 2004-07-29
WO2004063191A1 (en) 2004-07-29
IS7969A (is) 2005-08-02
CN100457752C (zh) 2009-02-04
US7482340B2 (en) 2009-01-27
NO20053730D0 (no) 2005-08-03
JP2006516271A (ja) 2006-06-29
EP1583759A1 (en) 2005-10-12
IL169435A0 (en) 2007-07-04
EA008539B1 (ru) 2007-06-29
CA2512184A1 (en) 2004-07-29
AU2004203943B2 (en) 2009-09-17
HRP20050703A2 (en) 2005-10-31
AR042733A1 (es) 2005-06-29
CN1745078A (zh) 2006-03-08
UA81941C2 (ru) 2008-02-25
RS20050528A (en) 2007-06-04
PL378326A1 (pl) 2006-03-20
FI20030030A0 (fi) 2003-01-09
NZ541087A (en) 2008-04-30
MXPA05007435A (es) 2005-09-12
EA200501104A1 (ru) 2005-12-29
KR20050095601A (ko) 2005-09-29

Similar Documents

Publication Publication Date Title
NO20053730L (no) Pyridinderivater anvendelig for hemming av natrium/kalsium-utbyttingssystem
TW434227B (en) Novel N-benzylindole and benzopyrazole derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immune modulating effect
ES2362871T3 (es) Indoles sustituidos y su uso como inhibidores de la reabsorción de 5ht y como ligandos 5-ht.
JP3218037B2 (ja) 喘息および呼吸器官の炎症の治療に有用なヘテロサイクリックアミン類
EP0747368B1 (en) Derivatives of monocyclic polyamines, their preparation, and their use as antiviral agents
AU704839B2 (en) The use of heterocyclic compounds
JP2019112459A (ja) 急性、亜急性または慢性の咳を治療するためのジアミノピリミジンp2x3およびp2x2/3受容体モジュレーター
WO2004026841A1 (ja) 新規6−置換ウラシル誘導体及びアレルギー性疾患の治療剤
EP2205566A2 (fr) Dérives de nicotinamide. leur préparation et leur application en thérapeutique
CA2369103A1 (en) Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same
IL177291A0 (en) Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists
NO20065112L (no) Kinolinon-karboksamidforbindelser som 5-HT4 receptoragonister
WO2010109122A1 (fr) Derives de nicotinamide, leur preparation et leur application en therapeutique comme anticancereux
PE20060298A1 (es) Derivados de acido carboxilico de bencimidazolona
TW200307545A (en) Nicotinamide derivatives and a tiotropium salt in combination for the treatment of diseases
NO20075409L (no) Substituerte aminoalkyl- og amidoalkyl-benzopyranderivater
JP6434528B2 (ja) 置換ピリドン及びピラジノン、並びに好中球エラスターゼ活性の阻害剤としてのその使用
HUT67666A (en) Biphenylil methyl pyrimidine derivatives having angiotensine ii antagonistic activity and pharmaceutical compositions containing them
JP2016510785A (ja) カテプシンcの置換二環式1−カルボン酸(ベンジル−シアノ−メチル)−アミド阻害剤
AU658729B2 (en) 3-(1H-imidazol-1-ylmethyl)-1H-indole derivatives
NO20074622L (no) Metabolitter for NK-1 antagonister for brekninger
EA200001009A1 (ru) Производные пиридина, ингибирующие фосфодиэстеразу iv
KR960000884A (ko) 신규의 피리딜 n-옥사이드로 치환된 피리딜이미다졸 유도체 및 그의 제조방법
US6720327B2 (en) Lactone integrin antagonists
DK1370539T3 (da) HIV-inhiberende N-aminoimidazolderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application